108, PR1; (i) V. A. Brunet and D. O’Hagan, Angew. Chem., Int.
Ed., 2008, 47, 1179.
4 For recent examples: (a) Y. Li and J. Hu, Angew. Chem., Int. Ed.,
2005, 44, 5882; (b) Y. Li and J. Hu, Angew. Chem., Int. Ed., 2007,
46, 2489; (c) J. Liu, L. Zhang and J. Hu, Org. Lett., 2008, 10, 5377;
(d) H. Li, S. Zhang, C. Yu, X. Song and W. Wang, Chem.
Commun., 2009, 2136; (e) X. Han, J. Luo, C. Liu and Y. Lu,
Chem. Commun., 2009, 2044.
5 (a) G. W. Gribble, J. Chem. Educ., 1973, 50, 460; (b) R. H. Abeles
and A. L. Maycock, Acc. Chem. Res., 1976, 9, 313;
(c) J. Kollonitsch, A. A. Patchett, S. Marburg, A. L. Maycock,
L. M. Perkins, G. A. Doldouras, D. E. Duggan and S. D. Aster,
Nature, 1978, 274, 906; (d) J. Kollonitsch, in Biomedicinal Aspects
of Fluorine Chemistry, ed. R. Filler and Y. Kobayashi, Elsevier
Biomedical Press and Kodansha Ltd, New York, Tokyo, 1982,
p. 93; (e) R. B. Silverman and S. M. Nanavati, J. Med. Chem.,
1990, 33, 931; (f) D. O’Hagan and H. S. Rzepa, Chem. Commun.,
1997, 645.
Scheme 1 A gram-scale synthesis and practical synthesis of enantio-
pure monofluorinated ibuprofen.
6 (a) T. Fukuzumi, N. Shibata, M. Sugiura, H. Yasui, S. Nakamura
and T. Toru, Angew. Chem., Int. Ed., 2006, 45, 4973; (b) S. Mizuta,
N. Shibata, Y. Goto, T. Furukawa, S. Nakamura and T. Toru,
J. Am. Chem. Soc., 2007, 129, 6394; (c) T. Furukawa, N. Shibata,
S. Mizuta, S. Nakamura, T. Toru and M. Shiro, Angew. Chem.,
Int. Ed., 2008, 47, 8051.
Scheme 2 Synthesis of monofluorinated naproxen.
7 (a) C. Ni, Y. Li and J. Hu, J. Org. Chem., 2006, 71, 6829; (b) C. Ni,
L. Zhang and J. Hu, J. Org. Chem., 2008, 73, 5699.
In summary, we found that [Ir(COD)Cl]2/phosphoramidite
1a is an efficient catalytic system for highly regio- and enantio-
selective allylic alkylation of fluorobis(phenylsulfonyl)methane.
The monofluoromethylated products could be transformed to
the fluorobis(phenylsulfonyl)methylated ibuprofen family in a
highly efficient manner.
8 (a) G. K. S. Prakash, S. Chacko, S. Alconcel, T. Stewart,
T. Mathew and G. A. Olah, Angew. Chem., Int. Ed., 2007, 46,
4933; (b) G. K. S. Prakash, I. Ledneczki, S. Chacko and
G. A. Olah, Org. Lett., 2008, 10, 557; (c) G. K. S. Prakash,
X. Zhao, S. Chacko, F. Wang, H. Vaghoo and G. A. Olah,
Beilstein J. Org. Chem., 2008, 4, 17; (d) G. K. S. Prakash,
S. Chacko, H. Vaghoo, N. Shao, L. Gurung, T. Mathew and
G. A. Olah, Org. Lett., 2009, 11, 1127.
9 For Pd-catalyzed allylic alkylation of prochiral fluoro-containing
nucleophiles, see: (a) M. Nakamura, A. Hajra, K. Endo and
E. Nakamura, Angew. Chem., Int. Ed., 2005, 44, 7248;
(b) J. T. Mohr, D. C. Behenna, A. M. Harned and B. M. Stoltz,
Angew. Chem., Int. Ed., 2005, 44, 6924; (c) E. C. Burger,
B. R. Barron and J. A. Tunge, Synlett, 2006, 2824;
We gratefully acknowledge the NSFC (20872159, 20821002
and 20942003), National Basic Research Program of China
(973 Program 2009CB825300), and Innovative Program of
Shanghai Education Committee (09ZZ36) for generous financial
support.
´
(d) E. Be
J.-F. Paquin, J. Am. Chem. Soc., 2007, 129, 1034; (e) E. Be
C. Houze, N. Guimond, K. Cantin and J.-F. Paquin, Chem.
´
langer, K. Cantin, O. Messe, M. Tremblay and
´
´
langer,
Notes and references
´
1 (a) Biomedical Fontiers of Fluorine Chemistry, ed. I. Ojima,
J. R. McCarthy and J. T. Welch, Washington DC, 1996;
(b) Organofluorine Compounds. Chemistry and Applications,
ed. T. Hiyama, Springer, New York, 2000; (c) B. E. Smart,
Commun., 2008, 3251. For recent examples using FBSM as nucleo-
philes, see: (f) H. W. Moon, M. J. Cho and D. Y. Kim, Tetrahedron
Lett., 2009, 50, 4896; (g) S.-L. Zhang, Y.-N. Zhang, Y.-F. Ji, H. Li
and W. Wang, Chem. Commun., 2009, 4886.
J. Fluorine Chem., 2001, 109, 3; (d) K. Muller, C. Faeh and
F. Diederich, Science, 2007, 317, 1881.
10 (a) H. He, X.-J. Zheng, Y. Li, L.-X. Dai and S.-L. You, Org. Lett.,
2007, 9, 4339; (b) W.-B. Liu, H. He, L.-X. Dai and S.-L. You,
Org. Lett., 2008, 10, 1815; (c) W.-B. Liu, H. He, L.-X. Dai and
S.-L. You, Synthesis, 2009, 2076; (d) H. He, W.-B. Liu, L.-X. Dai
and S.-L. You, J. Am. Chem. Soc., 2009, 131, 8346.
¨
2 (a) Biomedicinal Aspects of Fluorine Chemistry, ed. R. Filler and
Y. Kobayashi, Elsevier Biomedical Press and Kodansha Ltd,
New York, 1982; (b) Organofluorine Compounds in Medicinal
Chemistry and Biomedical Applications, ed. R. Filler,
Y. Kobayashi and L. M. Yagupolskii, Elsevier, Amsterdam,
1993; (c) R. D. Chambers, Fluorine in Organic Chemistry,
Blackwell Publishing, Oxford, UK, 2004; (d) P. Kirsch, Modern
Fluoroorganic Chemistry, Wiley-VCH, Weinheim, 2004.
3 For reviews, see: (a) B. J. Mann, Chem. Soc. Rev., 1987, 16, 381;
(b) J. A. Wilkinson, Chem. Rev., 1992, 92, 505; (c) G. K. S. Prakash
and A. K. Yudin, Chem. Rev., 1997, 97, 757; (d) R. P. Singh and
J. M. Shreeve, Tetrahedron, 2000, 56, 7613; (e) B. R. Langlois and
T. Billard, Synthesis, 2003, 185; (f) J.-A. Ma and D. Cahard, Chem.
Rev., 2004, 104, 6119; (g) G. K. S. Prakash and J. Hu, Acc. Chem.
Res., 2007, 40, 921; (h) J.-A. Ma and D. Cahard, Chem. Rev., 2008,
11 For reviews, see: (a) R. Takeuchi and S. Kezuka, Synthesis, 2006,
3349; (b) G. Helmchen, A. Dahnz, P. Dubon, M. Schelwies and
¨
R. Weihofen, Chem. Commun., 2007, 675; (c) G. Helmchen,
Iridium-Catalyzed Asymmetric Allylic Substitutions, in Iridium
Complexes in Organic Synthesis, ed. L. A. Oro and C. Claver,
Wiley-VCH, Weinheim, 2009, ch. 9.
12 P. H. Carlsen, T. Katsuki, V. S. Martin and K. B. Sharpless,
J. Org. Chem., 1981, 46, 3936.
13 The ee values of 6af and 6aj were determined by chiral HPLC of
their methyl ester derivatives, see ESIw.
14 B. S. Bal, W. E. Childers, Jr and H. W. Pinnick, Tetrahedron, 1981,
37, 2091.
ꢀc
This journal is The Royal Society of Chemistry 2009
6606 | Chem. Commun., 2009, 6604–6606